These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 26219895

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    Zhang W, Hou T, Niu C, Song L, Zhang Y.
    PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519
    [Abstract] [Full Text] [Related]

  • 5. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
    Niu C, Sun X, Zhang W, Li H, Xu L, Li J, Xu B, Zhang Y.
    Int J Mol Sci; 2016 Oct 20; 17(10):. PubMed ID: 27775588
    [Abstract] [Full Text] [Related]

  • 6. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W, He W, Shi Y, Zhao J, Liu S, Zhang F, Yang J, Xie C, Zhang Y.
    Int J Oncol; 2017 Jan 20; 50(1):173-184. PubMed ID: 27909716
    [Abstract] [Full Text] [Related]

  • 7. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
    Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, He ZW, Zeng JX, Zhang CF.
    Mol Med Rep; 2017 Feb 20; 15(2):605-612. PubMed ID: 28000881
    [Abstract] [Full Text] [Related]

  • 8. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
    Zhou YW, Li R, Duan CJ, Gao Y, Cheng YD, Zhang CF.
    Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30126850
    [Abstract] [Full Text] [Related]

  • 9. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
    Shen HW, Tan JF, Shang JH, Hou MZ, Liu J, He L, Yao SZ, He SY.
    Arch Gynecol Obstet; 2016 Aug 31; 294(2):333-42. PubMed ID: 26695643
    [Abstract] [Full Text] [Related]

  • 10. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 11. C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer.
    Cheang TY, Zhou HY, Chen W, Zhang B, Liu L, Yang J, Wang S, Li H.
    J Transl Med; 2016 Feb 17; 14():54. PubMed ID: 26883017
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W, Peng T, Zhou Y.
    J Cancer Res Ther; 2017 Feb 17; 13(5):801-806. PubMed ID: 29237907
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. C14orf166 Is a Biomarker for Predicting Hepatocellular Carcinoma Recurrence.
    Chen J, Chen J, Gong Y, Zou B, Liu X, Ding L, Huang J, Zhang B, Li J.
    J Invest Surg; 2020 Dec 17; 33(10):914-923. PubMed ID: 30907217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Expression of metastasis tumor-associated protein 2 in cervical squamous carcinoma and 
its relationship with prognosis].
    Xiao L, Huang S, Cheng H, Chen J.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct 28; 41(10):1031-1038. PubMed ID: 27807324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.